BioAge Labs Inc. (BIOA)
NASDAQ: BIOA
· Real-Time Price · USD
3.96
-0.19 (-4.58%)
At close: May 06, 2025, 3:59 PM
4.04
2.02%
After-hours: May 06, 2025, 06:24 PM EDT
-4.58% (1D)
Bid | 4.02 |
Market Cap | 141.97M |
Revenue (ttm) | n/a |
Net Income (ttm) | -71.11M |
EPS (ttm) | -6.63 |
PE Ratio (ttm) | -0.6 |
Forward PE | -1.58 |
Analyst | Hold |
Ask | 4.44 |
Volume | 134,424 |
Avg. Volume (20D) | 238,225 |
Open | 4.14 |
Previous Close | 4.15 |
Day's Range | 3.95 - 4.14 |
52-Week Range | 2.88 - 26.62 |
Beta | 0.50 |
About BIOA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BIOA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BIOA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+4.88%
BioAge Labs shares are trading higher after the co...
Unlock content with
Pro Subscription
4 months ago
-76.85%
BioAdge Labs shares are trading lower after Jefferies downgraded the stock from Buy to Hold and Citigroup downgraded the stock from Buy to Neutral. Additionally, both firms cut their price target on the stock to $7.

1 month ago · accessnewswire.com
March 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BIOANEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities la...